Filtern
Dokumenttyp
- Zeitschriftenartikel (22)
Referierte Publikation
- ja (22) (entfernen)
Schlagworte
- Deoxynivalenol (3)
- Glucuronidation (3)
- Phase I metabolism (3)
- Cyanotoxin (2)
- Cylindrospermopsin (2)
- ERM (2)
- Food (2)
- Fusarium mycotoxins (2)
- HPLC-MS/MS (2)
- Hydroxylation (2)
- Masked mycotoxins (2)
- Metabolism (2)
- Quantification (2)
- 3,4,4'-trichlorocarbanilide (1)
- Acetyl-DON (1)
- Alpha-zearalenol (1)
- Bioaccumulation (1)
- Biosynthesis (1)
- Bran (1)
- Brassicaceae (1)
- Brominated flame retardant (1)
- Caco-2 cells (1)
- Cis-ZEN (1)
- Claviceps purpurea (1)
- Cleanup effectiveness (1)
- Conjugation (1)
- Cyanobacterial toxin (1)
- Cytochrome P-450 (1)
- Cytochromes (1)
- DON-3-glucoside (1)
- Deoxynivalenol (DON) (1)
- Depletion kinetics (1)
- Detoxification (1)
- Diaporthe toxica (1)
- Dynamic light scattering (1)
- Ergotamine (1)
- Ergotoxine (1)
- Exposure source (1)
- Fermentation (1)
- Field-flow fractionation (1)
- Flour extraction (1)
- Food fermentation (1)
- Germination (1)
- HPLC-FLD (1)
- HRMS (1)
- Harmful algal bloom (1)
- HepaRG cells (1)
- Hepatic metabolism (1)
- Human health (1)
- Human recombinant UGT (1)
- In vitro digestion (1)
- Inter-species comparison (1)
- Isotopic labeled internal standard (1)
- LC-HRMS (1)
- LC-MS/MS (1)
- Lebensmittel (1)
- Liver tissue fractions (1)
- Lupins (1)
- Malting (1)
- Masked mycotoxin (1)
- Mass spectrometry (1)
- Metabolites (1)
- Microbial conversion (1)
- Microsomes (1)
- Modified mycotoxins (1)
- Multi-mycotoxin determination (1)
- Mycotoxin biotransformation (1)
- Mycotoxins (1)
- Mycotoxins and fungal metabolites (1)
- Mykotoxine (1)
- Nivalenol (1)
- Okadaic acid (1)
- Phase II metabolism (1)
- Phomopsin A (1)
- Plant systemic availability (1)
- Quality assurance (1)
- Rapid and validated methods (1)
- Recovery rate (1)
- Referenzmaterial (1)
- Regulations (1)
- Rhizopus and Aspergillus oryzae (1)
- Rye (1)
- SIDA (1)
- Sampling (1)
- Silver nanoparticles (1)
- Small-angle X-ray scattering (1)
- Spin-columns (1)
- Stability (1)
- Stable isotope dilution assay (1)
- Surface water (1)
- Trichothecene (1)
- UPLC-MS/MS (1)
- Uridine-diphosphoglucuronyltransferases (UGT) (1)
- Vegetable plants (1)
- Zearalenone (1)
- Zearalenone sulfate (1)
- Zearalenone-sulfate (1)
- a-zearalenol (1)
Organisationseinheit der BAM
Orally ingested nanoparticles may overcome the gastrointestinal barrier, reach the circulatory system, be distributed in the organism and cause adverse health effects. However, ingested nanoparticles have to pass through different physicochemical environments, which may alter their properties before they reach the intestinal cells. In this study, silver nanoparticles are characterised physicochemically during the course of artificial digestion to simulate the biochemical processes occurring during digestion. Their cytotoxicity on intestinal cells was investigated using the Caco-2 cell model. Using field-flow fractionation combined with dynamic light scattering and small-angle X-ray scattering, the authors found that particles only partially aggregate as a result of the digestive process. Cell viabilities were determined by means of CellTiter-Blue® assay, 4',6-diamidino-2-phenylindole-staining and real-time impedance. These measurements reveal small differences between digested and undigested particles (1–100 µg/ml or 1–69 particles/cell). The findings suggest that silver nanoparticles may indeed overcome the gastrointestinal juices in their particulate form without forming large quantities of aggregates. Consequently, the authors presume that the particles can reach the intestinal epithelial cells after ingestion with only a slight reduction in their cytotoxic potential. The study indicates that it is important to determine the impact of body fluids on the nanoparticles of interest to provide a reliable interpretation of their nano-specific cytotoxicity testing in vivo and in vitro.
Hexabromocyclododecane enantiomers: microsomal degradation and patterns of hydroxylated metabolites
(2011)
The degradation of the enantiomers of α-, β-, and γ-hexabromocyclododecane (HBCD) by phase I metabolism was investigated using induced rat liver microsomes. HBCD isomers were quantified using HPLC-MS/MS (ESI-) after separation on a combination of a reversed phase and a chiral analytical column. The degradation of all six isomers followed first-order kinetics and the estimated half-lives ranged from 6.3 min for both β-HBCD enantiomers to 32.3 min in case of (+)-γ-HBCD. (+)-α- and (–)-γ-HBCD displayed significantly shorter half-lives than their corresponding antipodes. It could be shown that this degradation led to a significant enrichment of the first eluting enantiomers (–)-α- and (+)-γ-HBCD. Individual patterns of mono- and dihydroxylated derivatives obtained from each α- and γ-HBCD enantiomer were seen to be distinctly characteristic. The patterns of monohydroxylated HBCD derivatives detected in liver and muscle tissues of pollack, mackerel and in herring gull eggs were largely similar to those observed in the in vitro experiments with rat liver microsomes. This enabled individual hydroxy-HBCDs to be assigned to their respective parent HBCD enantiomers.